BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29235037)

  • 1. Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma.
    Mehrad M; Dupont WD; Plummer WD; Lewis JS
    Head Neck Pathol; 2018 Dec; 12(4):448-454. PubMed ID: 29235037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 7 in Oropharyngeal Squamous Cell Carcinoma: A Junctional Biomarker for Human Papillomavirus-Related Tumors.
    Woods RSR; Keegan H; White C; Tewari P; Toner M; Kennedy S; O'Regan EM; Martin CM; Timon CVI; O'Leary JJ
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):702-710. PubMed ID: 28082347
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection.
    Morbini P; Capello GL; Alberizzi P; Benazzo M; Paglino C; Comoli P; Pedrazzoli P
    Histol Histopathol; 2015 Jul; 30(7):833-9. PubMed ID: 25644820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 7 and 19 expression in oropharyngeal and oral squamous cell carcinoma.
    Woods RSR; Callanan D; Jawad H; Molony P; Werner R; Heffron C; Feeley L; Sheahan P
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1435-1443. PubMed ID: 34046748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin7 expression in histologic and cytologic specimens of cystic neck metastasis from HPV positive squamous cell carcinoma of the tonsil: A case report.
    Cho YK; Lee SJ; Woo JJ; Lee H; Lee H
    Diagn Cytopathol; 2018 Apr; 46(4):331-335. PubMed ID: 29048728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV infection in oropharyngeal squamous cell carcinomas: correlation with tumor size.
    Gletsou E; Papadas TA; Baliou E; Tsiambas E; Ragos V; Armata IE; Metaxas GE; Fotiades PP
    J BUON; 2018; 23(2):433-438. PubMed ID: 29745089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous and Neuroendocrine Specific Immunohistochemical Markers in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Study.
    Lewis JS; Chernock RD; Bishop JA
    Head Neck Pathol; 2018 Mar; 12(1):62-70. PubMed ID: 28528398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
    Shankar A; Crouch DH; Macluskey M
    Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
    Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.
    Thompson ED; Stelow EB; Mills SE; Westra WH; Bishop JA
    Am J Surg Pathol; 2016 Apr; 40(4):471-8. PubMed ID: 26735857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.
    Harbison RA; Kubik M; Konnick EQ; Zhang Q; Lee SG; Park H; Zhang J; Carlson CS; Chen C; Schwartz SM; Rodriguez CP; Duvvuri U; Méndez E
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma.
    Wakisaka N; Yoshida S; Kondo S; Kita M; Sawada-Kitamura S; Endo K; Tsuji A; Nakanish Y; Murono S; Yoshizaki T
    Histopathology; 2015 May; 66(6):771-80. PubMed ID: 25039283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.